What is ClaroNav?
ClaroNav operates at the intersection of advanced medical engineering and surgical precision. By developing sophisticated image-guided navigation systems, such as the Navident EVO and MicronMapper EVO, the company addresses critical inefficiencies in dental and surgical workflows. Their technology is designed to provide high-fidelity spatial awareness, enabling practitioners to achieve superior clinical outcomes through portable and cost-effective hardware solutions. Beyond its direct-to-practice offerings, ClaroNav maintains a robust OEM business model, allowing for the integration of its customizable navigation modules into broader medical device ecosystems. This dual-pronged approach solidifies its standing as a key innovator in the digital dentistry and surgical robotics sectors.
How much funding has ClaroNav raised?
ClaroNav has raised a total of $1.5M across 1 funding round:
Share Placement
$1.5M
Share Placement (2020): $1.5M, investors not publicly disclosed
Key Investors in ClaroNav
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for ClaroNav?
With this major strategic investment, ClaroNav is poised to transition from a specialized technology provider to a dominant force in the global surgical navigation market. The capital will likely be deployed toward expanding the company's R&D capabilities, specifically focusing on the miniaturization of sensors and the enhancement of AI-driven image processing algorithms. Furthermore, the firm is expected to leverage these funds to strengthen its international distribution networks and pursue strategic partnerships with larger medical device conglomerates. As the demand for minimally invasive, high-precision surgical tools continues to rise, ClaroNav's focus on simplicity and accuracy positions it to capture significant market share, potentially setting the stage for future enterprise-level expansion or acquisition opportunities.
See full ClaroNav company page
